BresMed

BresMed was founded in 2006 and currently has more than 145 employees in the UK, Ireland, India, the Netherlands, and the United States. BresMed is an independent health economics and outcomes research (HEOR) consulting company dedicated to open collaboration with its healthcare clients. BresMed's services provide extensive support to top pharmaceutical companies, medical device manufacturers, and small biopharmaceutical companies at the global, European, and member levels. BresMed has a portfolio that covers a complete product development pipeline from early planning to implementation and launch. Their services are divided into three interconnected groups: evidence review, evidence development and communication, with a common focus on strategy and insights to ensure projects meet client needs, helping them define, develop, and execute successful HEOR strategies. BresMed staff have extensive experience in HTA submissions and reimbursement (including NICE, SMC, AWMSG, NCPE, CADTH, PBAC, TLV), gained from industry, consulting, and academia. By combining BresMed's technical expertise with strategic knowledge, they offer clients a broad and deep range of experience.